MedTrace Logo

R3® Acetabular System in Patients With Degenerative Hip Disease

NCT01407029 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 158

Last updated 2017-04-25

No results posted yet for this study

Summary

This is a prospective, non-randomized, consecutive series, multicenter clinical study that will include patients who will have total hip replacement with the R3 Acetabular System.

Conditions

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Richard McCalden, MD · London Health Science Centre-University Hospital London Ontario

  • Colin Burnell, MD · Concordia Hospital, Winnipeg, Canada

  • James Comadoll, MD · Ro Medical Orthopedics, Salisbury NC

  • Richard Steinfeld, MD · Orthopaedic Center of Vero Beach, Vero Beach, FL

  • Craig Della Valle, MD · Rush University Medical Center

  • John Masonis, MD · OrthoCarolina Research Institute

  • Ryan Nunley, MD · Washington University Orthopedics

  • Michael Dunbar, MD · Halifax Infirmary

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2017-03-14
Completion
2017-03-14

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01407029 on ClinicalTrials.gov